文献速递气道管理术前评估与围术期医学

无创通气预氧合对低氧血症患者插管后器官衰竭的影响:随机临床试验

Effect of preoxygenation using non-invasive ventilation before intubation on subsequent organ failures in hypoxaemic patients: a randomised clinical trial.
PubMed 文献 · Br J Anaesth · 2017-11-23

这项多中心随机开放标签试验将低氧血症危重患者分为无创通气(NIV)预氧合组(99例)与面罩预氧合组(102例),插管前给予100% FiO2持续3分钟。主要终点为插管后7天内SOFA评分最大值,两组无显著差异(NIV组9[6-12] vs 面罩组10[6-12],P=0.65)。在随机化前已接受NIV治疗的患者中,面罩组不良事件发生率显著增加(OR=5.23[1.61;16.99],P=0.0059)。

要点

  • NIV预氧合未降低低氧血症危重患者插管后7天内器官功能障碍发生率
  • 插管前已接受NIV者不应因预氧合而中断NIV,否则不良事件风险增加
  • 面罩预氧合在随机化前已用NIV的患者中不良事件OR为5.23

核心结论

  • 与常规面罩预氧合相比,NIV预氧合未能减少低氧血症危重患者插管后的器官功能障碍。
  • 对于插管决定前已接受NIV治疗的患者,不应为预氧合而中断NIV。

研究设计与样本

  • 多中心、随机、开放标签试验,比较插管前3分钟100% FiO2经NIV(99例)与面罩(102例)预氧合。
  • 主要终点为插管后7天内序贯器官衰竭评估(SOFA)评分的最大值。

主要发现

  • 插管后7天内SOFA评分最大值中位数(四分位距)两组无显著差异:NIV组9(6-12) vs 面罩组10(6-12),P=0.65。
  • 在随机化前接受NIV治疗的患者中,随机至面罩组的不良事件发生显著增加,OR=5.23(1.61;16.99),P=0.0059。

临床怎么用

  • 低氧血症危重患者插管前预氧合可不常规使用NIV替代面罩,因未显示减少器官功能障碍的获益。
  • 对已接受NIV治疗的患者,插管前预氧合不应中断NIV,以避免不良事件增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous data showed that non-invasive ventilation (NIV) applied for 3 min before tracheal intubation ensured better oxygenation compared with using a non-rebreather bag-valve-mask. We aimed to determine whether preoxygenation using NIV is effective in reducing the incidence of organ dysfunction in hypoxaemic, critically ill patients in intensive care. METHODS: A multicentre, randomised, open-label trial evaluating 100% FiO2 administered with NIV (99 patients) vs with face mask (102 patients) for 3 min before tracheal intubation. The primary endpoint was the maximal value of Sequential Organ Failure Assessment score within 7 days after intubation. RESULTS: The median (inter-quartile range) values of the maximal value of the Sequential Organ Failure Assessment score within 7 days post-intubation were not significantly different between the two randomised groups: nine (6-12) in the NIV group vs 10 (6-12) in the face mask group (P=0.65). In patients treated by NIV prior to the randomisation, there was a significant increase in the occurrence in adverse events in patients randomised to face mask [odds ratio=5.23 (1.61;16.99), P=0.0059]. CONCLUSIONS: This study failed to demonstrate any benefits of using NIV as a preoxygenation method to reduce organ dysfunction compared with usual preoxygenation in hypoxaemic, critically ill patients requiring tracheal intubation for invasive ventilation. NIV should not be discontinued for preoxygenation in the cases of patients treated by NIV before the decision to intubate. CLINICAL TRIAL REGISTRATION: NCT00472160.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Baillard C, Prat G, Jung B, et al. Effect of preoxygenation using non-invasive ventilation before intubation on subsequent organ failures in hypoxaemic patients: a randomised clinical trial. Br J Anaesth. 2017. PMID: 29406184. doi:10.1016/j.bja.2017.11.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。